30 Apr, EOD - Indian

SENSEX 80242.24 (-0.06)

Nifty 50 24334.2 (-0.01)

Nifty Bank 55087.15 (-0.55)

Nifty IT 35794.95 (-0.35)

Nifty Midcap 100 54124.9 (-0.85)

Nifty Next 50 64508.85 (-0.59)

Nifty Pharma 21772.45 (0.44)

Nifty Smallcap 100 16448.85 (-1.73)

30 Apr, EOD - Global

NIKKEI 225 36452.3 (1.13)

HANG SENG 22119.41 (0.51)

S&P 5644.91 (0.98)

LOGIN HERE

companylogoJeena Sikho Lifecare Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 535446 | NSE Symbol : JSLL | ISIN : INE0J5801011 | Industry : Pharmaceuticals - Indian - Formulations |


Chairman's Speech

Dear Stakeholders,

Dear Shareholders,

It brings me immense pleasure to put forth the 5th Annual Report of your Company, Jcena Sikho Lifecare Limited for the Financial Year 2021-2022.1 would like to thank all our shareholders who have reposed their trust in the Company during the Initial Public Offering.

We are coming back to our normal life after two years of Covidl9 pandemic. Whatever happened is in past, we have to look towards the future and build a great society consist of good-hearted people who look for each other. I would like to place on record my appreciation on behalf of the Board of Directors of the entire Jeena Sikho family who has worked tirelessly even in exceptional circumstances for the greater good of the society.

Our company also suffered due to this global pandemic and now we arc in transition period, collecting our pieces together and held our head high. While the Indian economy is still struggling to overcome the rippling effects of the COVID-19 pandemic, we have reported another year of steady revenue growth.

While wc arc applying our learnings from the last two years of the pandemic to enhance the efficiencies of our operations and build robust supply chains to function with minimum disruption in such exceptional circumstances, we also plan on reassessing our business continuity plan this year to come up with better synergies.

Our people are our most valuable asset, with their commitment and dedication, I am confident that we will continue to meet the demands of our consumers, live up to their expectations by providing long-term value, and generate sustainable long-term growth. While we acknowledge the progress that has been made, we also understand that we still have a long way to go.

I would like to take this opportunity to thank the Board of Directors and our advisors for their continued guidance and trust I would also like to thank our shareholders and customers for their unwavering support and faith in us and for making Jeena Sikho, India's most trusted name. I look forward to your continued support while we remain committed to delivering quality.

We look forward to the future with excitement. We are at an early stage but we are very optimistic. Take care.

Sincerely

Manish Grover

Chairman

   

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +